44.6 F
New York
Wednesday, November 25, 2020

Atossa Therapeutics Inc. (NASDAQ:ATOS) Finding Strong Support

Must read

Fate Therapeutics Inc. (NASDAQ:FATE) is Gaining Momentum on Earnings Catalyst

Fate Therapeutics Inc. (FATE) shares are trading at higher $54.29 and the avg recommendation for the stock is Strong Buy, while the current analyst...

PDC Energy Inc. (NASDAQ:PDCE) on the Path to Profitability

PDC Energy Inc. (PDCE) shares are trading at higher $17.35 and the avg recommendation for the stock is Strong Buy, while the current analyst...

Can We Expect More Volatility From eXp World Holdings Inc. (EXPI)?

eXp World Holdings Inc. (EXPI) shares are trading at higher $50.57 and the avg recommendation for the stock is Strong Buy, while the current...

Levi Strauss & Co. (NYSE:LEVI) Recent Earnings Shows Major Promise

Levi Strauss & Co. (LEVI) shares are trading at higher $19.01 and the avg recommendation for the stock is Strong Buy, while the current...

Atossa Therapeutics Inc. (ATOS) shares are trading at higher $3.71 and the avg recommendation for the stock is Moderate Buy.

To add more color to this target, the company’s high over the last year is $5.08 and the low is $0.75. Over the last 52 weeks, ATOS is down -26.97% while the S&P 500 is down 0.00%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, ATOS reported a profit of $30000.0. Atossa Therapeutics Inc. also saw revenues increase to $3.94 million. In addition, ATOS has free cash flow of -$5.47 million as of 06-2020. The company’s EBITDA came in at -$3.92 million which compares well with its peers.

ATOS Return on Equity (ROE) is -127.90%, and its Return on Assets is -112.10%. All told, it is clear that, ATOS needs to be on your watchlist.

Find out when ATOS reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. ATOS has a short ratio of 0.18 and outstanding shares of 9.13M.

Company Outlook

ATOS has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 0.64 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at -1.77. Atossa Therapeutics Inc. ATOS also noted assets of $10.21 million at the end of the last quarter. Investors should also keep an eye on sector updates as ATOS has historically followed its peers on positive news.

All told, Atossa Therapeutics Inc. ATOS has strung together solid data and demonstrated underlying fundamentals. At its current valuation, ATOS represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Atossa Therapeutics Inc. ATOS is now commanding a market cap of 31.20M. ATOS is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of ATOS stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in ATOS, either long or short, and we have not been compensated for this article.

Latest article

Cadence Bancorporation (CADE)’s Stock is Jumping, Here is Why

Cadence Bancorporation (CADE) shares are trading at higher $14.58 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Can We Expect More Volatility From Covanta Holding Corporation (CVA)?

Covanta Holding Corporation (CVA) shares are trading at higher $12.16 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

When Will Investors Bancorp Inc. (ISBC) Slow Down

Investors Bancorp Inc. (ISBC) shares are trading at higher $9.77 and the avg recommendation for the stock is Strong Buy, while the current analyst...

SINA Corporation (NASDAQ:SINA) is Gaining Momentum on Earnings Catalyst

SINA Corporation (SINA) shares are trading at lower $43.25 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Is the Rough Ride Over for Qorvo Inc. (QRVO)

Qorvo Inc. (QRVO) shares are trading at higher $149.20 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...